about
Aptamers in diagnostics and treatment of viral infectionsUse of Aptamers as Diagnostics Tools and Antiviral Agents for Human VirusesLarge scale analysis of the mutational landscape in HT-SELEX improves aptamer discoveryAptaTRACE Elucidates RNA Sequence-Structure Motifs from Selection Trends in HT-SELEX ExperimentsPredictive and comparative analysis of Ebolavirus proteinsThe Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencingReverse genetics systems as tools for the development of novel therapies against filoviruses.Strategies in Ebola virus disease (EVD) diagnostics at the point of care.Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics.Ebola virus outbreak, updates on current therapeutic strategies.Status and Prospects of Aptamers as Drug Components.Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.Aptamers against pathogenic microorganisms.Therapeutics for postexposure treatment of Ebola virus infection.Herbal Lead as Ideal Bioactive Compounds Against Probable Drug Targets of Ebola Virus in Comparison with Known Chemical Analogue: A Computational Drug Discovery Perspective.DhITACT: DNA Hydrogel Formation by Isothermal Amplification of Complementary Target in Fluidic Channels.Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.Label-free logic modules and two-layer cascade based on stem-loop probes containing a G-quadruplex domain.Advancing rapid point-of-care viral diagnostics to a clinical setting
P2860
Q27014527-D1CC4D02-1E78-41AB-948A-7CAA40A75EF8Q28079654-8F93549D-9F2C-4AFB-BB6C-3E4B12B96A66Q35600644-D8311B44-1AA0-4510-BCDA-4941727166CCQ36088479-6CA0B69B-EA4B-4B32-91C1-12EB380E7846Q36189492-3BCD46BD-D981-4058-BA46-816F0D66D1E3Q36411422-7BD71148-0AAA-4FCC-AC9F-B2CE03BDA2FCQ38244444-652FA66E-A51A-4266-917B-9A8602A54F80Q38371191-E83567BF-E7EA-4BB2-B60F-349F52F69FDFQ38443249-AACD3550-F1DC-4F16-B151-2315A54369A1Q38473251-C0031142-386D-4665-BF74-C3058F0F78BBQ38488502-64635407-7776-40FD-9066-0EC3FB5F5F81Q38491805-14097A36-0D00-4DBD-8EA0-7BB004A19BFBQ38563672-5F6CDBA0-9720-48B2-BFB7-D6306F82833CQ38980947-9EA35541-848C-4B94-96D2-0E3B0C77F570Q40119093-0301880A-8FC1-4686-BD4D-B72F4A63E52FQ40157212-2CEEC063-88A3-4AC9-A275-5BF28773A5E6Q42934343-4890833B-3442-44D3-AD14-4D68A5FCF1B1Q48073780-D50086C9-B5A7-4400-ABA3-63D07C52A3D9Q56766086-8AE1966C-04F0-447C-8809-8B6C1E0C5CEE
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Development of RNA Aptamers Targeting Ebola Virus VP35
@ast
Development of RNA Aptamers Targeting Ebola Virus VP35
@en
Development of RNA Aptamers Targeting Ebola Virus VP35
@nl
type
label
Development of RNA Aptamers Targeting Ebola Virus VP35
@ast
Development of RNA Aptamers Targeting Ebola Virus VP35
@en
Development of RNA Aptamers Targeting Ebola Virus VP35
@nl
prefLabel
Development of RNA Aptamers Targeting Ebola Virus VP35
@ast
Development of RNA Aptamers Targeting Ebola Virus VP35
@en
Development of RNA Aptamers Targeting Ebola Virus VP35
@nl
P2093
P2860
P50
P356
P1433
P1476
Development of RNA Aptamers Targeting Ebola Virus VP35
@en
P2093
Daisy W Leung
Gaya K Amarasinghe
Jennifer M Binning
Priya Luthra
Tianjiao Wang
P2860
P304
P356
10.1021/BI400704D
P407
P577
2013-11-26T00:00:00Z